Dermatologic adverse events caused by biologic treatments - Pathogenesis and management.

Autor: Trefzer LK; Department of Dermatology and Venerology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Pilz AC; Department of Dermatology and Venerology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Eyerich K; Department of Dermatology and Venerology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Department of Dermatology and Allergy, Technical University of Munich, Munich, Germany.; Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
Jazyk: angličtina
Zdroj: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG [J Dtsch Dermatol Ges] 2024 Aug; Vol. 22 (8), pp. 1126-1136. Date of Electronic Publication: 2024 Jun 25.
DOI: 10.1111/ddg.15360
Abstrakt: Biologics are approved for various dermatologic, allergic, rheumatic, and gastroenterologic inflammatory diseases, as well as for numerous malignancies. The dermatologic adverse events from treatment with biologics may resemble primary inflammatory diseases but differ in pathogenesis. In this article, we describe five different pathogenic mechanisms of dermatologic adverse events. By studying these mechanisms, we hope to gain valuable insights into the pathogenesis of primary inflammatory diseases. In addition, in this article, we provide recommendations for the treatment and management of the dermatological adverse events induced by biologics.
(© 2024 Deutsche Dermatologische Gesellschaft (DDG).)
Databáze: MEDLINE
Externí odkaz: